These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 9812767)
41. Physical activity, skeletal muscle beta-adrenoceptor changes and oxidative metabolism in experimental chronic heart failure. Michel C; Chati Z; Mertes PM; Escanye JM; Zannad F Fundam Clin Pharmacol; 1998; 12(3):263-9. PubMed ID: 9646058 [TBL] [Abstract][Full Text] [Related]
42. Irreversible inactivation of beta-adrenergic receptors of C6 glioma cells. Synthesis and study of a thiol derivative of propranolol. Gozlan H; Homburger V; Lucas M; Bockaert J; Michelot R Biochimie; 1980; 62(7):455-62. PubMed ID: 6250644 [TBL] [Abstract][Full Text] [Related]
43. Quantitative relationship between beta-adrenergic receptor number and physiologic responses as studied with a long-lasting beta-adrenergic antagonist. Terasaki WL; Linden J; Brooker G Proc Natl Acad Sci U S A; 1979 Dec; 76(12):6401-5. PubMed ID: 42915 [TBL] [Abstract][Full Text] [Related]
44. [Pulmonary hemodynamics following experimental myocardial ischemia after the blockade of adrenergic receptors]. Evlakhov VI; Poiasov IZ Ross Fiziol Zh Im I M Sechenova; 2015 Jan; 101(1):44-53. PubMed ID: 25868325 [TBL] [Abstract][Full Text] [Related]
45. Beta-adrenergic receptors are involved in stress-related behavioral changes. Gorman AL; Dunn AJ Pharmacol Biochem Behav; 1993 May; 45(1):1-7. PubMed ID: 8100069 [TBL] [Abstract][Full Text] [Related]
46. An approach to analysis of radiolabeled ligand interactions with specific receptors. Manukhin BN; Nesterova LA; Smurova EA; Kichikulova TP Eur J Pharmacol; 1999 Dec; 386(2-3):279-88. PubMed ID: 10618480 [TBL] [Abstract][Full Text] [Related]
47. Beta-adrenoceptor blocking activity of diprafenone in anesthetized dogs: comparison with propafenone and propranolol. Greenberg S; Cantor E; Paul J J Cardiovasc Pharmacol; 1989 Sep; 14(3):444-53. PubMed ID: 2476625 [TBL] [Abstract][Full Text] [Related]
48. [Role of catecholamine in activating glycogenolysis in experimental myocardial infarct complicated by ventricular fibrillation]. Dolgova NP Kardiologiia; 1982; 22(7):101-5. PubMed ID: 6287086 [TBL] [Abstract][Full Text] [Related]
49. Blocking β-adrenergic signaling attenuates reductions in circulating leptin, cancellous bone mass, and marrow adiposity seen with dietary energy restriction. Baek K; Bloomfield SA J Appl Physiol (1985); 2012 Dec; 113(11):1792-801. PubMed ID: 22995391 [TBL] [Abstract][Full Text] [Related]
50. Pravastatin reverses the down-regulating effect of inflammation on beta-adrenergic receptors: a disease-drug interaction between inflammation, pravastatin, and propranolol. Clements JD; Jamali F Vascul Pharmacol; 2007 Jan; 46(1):52-9. PubMed ID: 16949884 [TBL] [Abstract][Full Text] [Related]
51. Beta-adrenergic responsiveness of papillary muscles in the rat postinfarction model. Qi X; Rouleau JL Can J Physiol Pharmacol; 1996 Oct; 74(10):1166-70. PubMed ID: 9022837 [TBL] [Abstract][Full Text] [Related]
52. Characterization of propranolol-resistant (-)-[125I]-cyanopindolol binding sites in rat soleus muscle. Roberts SJ; Molenaar P; Summers RJ Br J Pharmacol; 1993 Jun; 109(2):344-52. PubMed ID: 8102926 [TBL] [Abstract][Full Text] [Related]
53. [Beta-adrenergic receptor blockers in clinical practice]. Czuriga I; Edes I Orv Hetil; 2004 Sep; 145(38):1951-60. PubMed ID: 15535106 [TBL] [Abstract][Full Text] [Related]
54. Adrenergic receptor systems and unscheduled DNA synthesis in the rat brain. Sadile AG; Lamberti-D'Mello C; Cerbone A; Amoroso S; Annunziato L; Menna T; Buono C; Giuditta A Brain Res Bull; 1995; 37(2):139-48. PubMed ID: 7606489 [TBL] [Abstract][Full Text] [Related]
55. Exercise and beta-adrenergic regulation of rat cardiac myosin isoforms. Wade ME; Herb RA; Powers SK; Criswell D J Sports Med Phys Fitness; 1999 Mar; 39(1):42-6. PubMed ID: 10230168 [TBL] [Abstract][Full Text] [Related]
56. Interaction between Na+/phosphate-cotransporter and the adrenoceptors in myocardial depression. Onwochei MO; Ofori AO; Agodoa IL J Cardiovasc Pharmacol; 1998 Jan; 31(1):10-7. PubMed ID: 9456271 [TBL] [Abstract][Full Text] [Related]
57. Experimental studies of electroacupuncture on ventricular fibrillation threshold in rats with acute ischemic myocardium. Liu Z; Chen Y; Shi B; Ouyang X; Guan X J Tongji Med Univ; 1998; 18(2):90-3. PubMed ID: 10806832 [TBL] [Abstract][Full Text] [Related]
58. Reevaluation of the regulation of beta-adrenergic receptor binding by desipramine treatment. Riva MA; Creese I Mol Pharmacol; 1989 Jul; 36(1):211-8. PubMed ID: 2546051 [TBL] [Abstract][Full Text] [Related]
59. Human beta 1- and beta 2-adrenergic receptor binding and mediated accumulation of cAMP in transfected Chinese hamster ovary cells. Profile of nebivolol and known beta-adrenergic blockers. Pauwels PJ; Van Gompel P; Leysen JE Biochem Pharmacol; 1991 Oct; 42(9):1683-9. PubMed ID: 1681809 [TBL] [Abstract][Full Text] [Related]
60. Regulation of alpha 1-, beta 1-, and beta 2-adrenergic receptors in rat heart by norepinephrine. Zhao M; Hagler HK; Muntz KH Am J Physiol; 1996 Nov; 271(5 Pt 2):H1762-8. PubMed ID: 8945889 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]